Skeletal muscle dysfunction occurs in patients with chronic obstructive pulmonary disease
(COPD) and affects both ventilatory and nonventilatory muscle groups. It represents a very …

Various diseases can cause skeletal muscle atrophy, usually accompanied by inflammation,
mitochondrial dysfunction, apoptosis, decreased protein synthesis, and enhanced …

We defined respiratory sarcopenia as a coexistence of respiratory muscle weakness and
decreased respiratory muscle mass. Although respiratory muscle function is indispensable …

Obesity is a characteristic of COVID-19 patients and the risk of malnutrition can be
underestimated due to excess of fat: a paradoxical danger. Long ICU hospitalization …

Background Sarcopenia can contribute to negative outcomes in patients with various lung
diseases. However, whether sarcopenia affects prognosis in patients with idiopathic …

Body composition measurement using diagnostic computed tomography (CT) scans has
emerged as a method to assess sarcopenia (low muscle mass) in oncology patients …

Sarcopenia and osteoporosis are common musculoskeletal comorbidities of chronic
obstructive pulmonary disease (COPD) that seriously affect the quality of life and prognosis …

Change in body composition with skeletal muscle wasting, a major component of pulmonary
cachexia, is associated with mortality in chronic obstructive pulmonary disease and cancer …

The awareness of the presence and consequences of sarcopenia has significantly
increased over the past decade. Sarcopenia is defined as gradual loss of muscle mass and …

Background Muscle wasting is associated with prognosis in patients with chronic obstructive
pulmonary disease (COPD). The cross-sectional area of skeletal muscles on computed …